Cheeseman Keylon L, Ueyama Takehiko, Michaud Tanya M, Kashiwagi Kaori, Wang Demin, Flax Lindsay A, Shirai Yasuhito, Loegering Daniel J, Saito Naoaki, Lennartz Michelle R
Center for Cell Biology and Cancer Research, Albany Medical College, Albany, NY 12208, USA.
Mol Biol Cell. 2006 Feb;17(2):799-813. doi: 10.1091/mbc.e04-12-1100. Epub 2005 Nov 30.
Protein kinase C-epsilon (PKC-epsilon) translocates to phagosomes and promotes uptake of IgG-opsonized targets. To identify the regions responsible for this concentration, green fluorescent protein (GFP)-protein kinase C-epsilon mutants were tracked during phagocytosis and in response to exogenous lipids. Deletion of the diacylglycerol (DAG)-binding epsilonC1 and epsilonC1B domains, or the epsilonC1B point mutant epsilonC259G, decreased accumulation at phagosomes and membrane translocation in response to exogenous DAG. Quantitation of GFP revealed that epsilonC259G, epsilonC1, and epsilonC1B accumulation at phagosomes was significantly less than that of intact PKC-epsilon. Also, the DAG antagonist 1-hexadecyl-2-acetyl glycerol (EI-150) blocked PKC-epsilon translocation. Thus, DAG binding to epsilonC1B is necessary for PKC-epsilon translocation. The role of phospholipase D (PLD), phosphatidylinositol-specific phospholipase C (PI-PLC)-gamma1, and PI-PLC-gamma2 in PKC-epsilon accumulation was assessed. Although GFP-PLD2 localized to phagosomes and enhanced phagocytosis, PLD inhibition did not alter target ingestion or PKC-epsilon localization. In contrast, the PI-PLC inhibitor U73122 decreased both phagocytosis and PKC-epsilon accumulation. Although expression of PI-PLC-gamma2 is higher than that of PI-PLC-gamma1, PI-PLC-gamma1 but not PI-PLC-gamma2 consistently concentrated at phagosomes. Macrophages from PI-PLC-gamma2-/- mice were similar to wild-type macrophages in their rate and extent of phagocytosis, their accumulation of PKC-epsilon at the phagosome, and their sensitivity to U73122. This implicates PI-PLC-gamma1 as the enzyme that supports PKC-epsilon localization and phagocytosis. That PI-PLC-gamma1 was transiently tyrosine phosphorylated in nascent phagosomes is consistent with this conclusion. Together, these results support a model in which PI-PLC-gamma1 provides DAG that binds to epsilonC1B, facilitating PKC-epsilon localization to phagosomes for efficient IgG-mediated phagocytosis.
蛋白激酶C-ε(PKC-ε)转位至吞噬体并促进对IgG调理靶标的摄取。为了确定负责这种聚集的区域,在吞噬作用期间以及对外源脂质的反应中追踪绿色荧光蛋白(GFP)-蛋白激酶C-ε突变体。删除二酰基甘油(DAG)结合的εC1和εC1B结构域,或εC1B点突变体εC259G,会降低吞噬体处的积累以及对外源DAG的膜转位。GFP定量显示,εC259G、εC1和εC1B在吞噬体处的积累明显少于完整的PKC-ε。此外,DAG拮抗剂1-十六烷基-2-乙酰甘油(EI-150)阻断了PKC-ε的转位。因此,DAG与εC1B的结合是PKC-ε转位所必需的。评估了磷脂酶D(PLD)、磷脂酰肌醇特异性磷脂酶C(PI-PLC)-γ1和PI-PLC-γ2在PKC-ε积累中的作用。虽然GFP-PLD2定位于吞噬体并增强吞噬作用,但PLD抑制并未改变靶标的摄取或PKC-ε的定位。相反,PI-PLC抑制剂U73122降低了吞噬作用和PKC-ε的积累。虽然PI-PLC-γ2的表达高于PI-PLC-γ1,但PI-PLC-γ1而非PI-PLC-γ2始终聚集在吞噬体处。来自PI-PLC-γ2基因敲除小鼠的巨噬细胞在吞噬作用的速率和程度、PKC-ε在吞噬体处的积累以及对U73122的敏感性方面与野生型巨噬细胞相似。这表明PI-PLC-γ1是支持PKC-ε定位和吞噬作用的酶。PI-PLC-γ1在新生吞噬体中短暂酪氨酸磷酸化与这一结论一致。总之,这些结果支持了一个模型,即PI-PLC-γ1提供与εC1B结合的DAG,促进PKC-ε定位于吞噬体以实现高效的IgG介导的吞噬作用。